We found 39 results for your search.
BOSTON, Aug. 2, 2022 – Ariadne Labs, in collaboration with CaroNova, a health innovation incubator for the Carolinas, recently concluded the first phase of the Home Hospital Early Adopters Accelerator to support health care systems to further develop their own home hospital programs. Through this 40-week program, a total of 91 representatives from 18 health… Continue reading Ariadne Labs and CaroNova Bring Together 18 Health Systems to Develop Tools to Accelerate Home Hospital
In April 2021, just months after COVID-19 vaccines received emergency use authorization, Ariadne Labs and partners launched a major effort to get shots in arms – as many as possible, as quickly as possible. The founding premise of the Global Mass Vaccination Site Collaborative was that by exchanging information, techniques, and insights, those on the… Continue reading Ariadne Labs’ Global Mass Vaccination Collaborative: A Q&A with Eric Goralnick and Margaret Ben-Or
Boston, MA – Ariadne Labs, in collaboration with CaroNova, a health innovation incubator for the Carolinas, has launched the Home Hospital Early Adopters Accelerator Program to support health care systems to further develop their own home hospital programs. The program provides expertise in designing and managing home hospital programs via a network of hospitals who… Continue reading Ariadne Labs and CaroNova Launch Home Hospital Early Adopters Accelerator
Ambulatory & Primary Health Care Tools to support countries in building strong primary health care systems, from a case study examining how Costa Rica built its thriving system, to a measurement tool to help countries understand the strengths and weaknesses of their own system. BUILDING A THRIVING PRIMARY HEALTH CARE SYSTEM:THE STORY OF COSTA RICA… Continue reading TOOLS AND DOWNLOADS
Lisez ceci en français. July 30, 2021 By Stephanie Schorow for the Global Mass Vaccination Site Collaborative Schools in the United States have been thought as the great equalizer of American society, even if they often fall short of that lofty goal. Now schools could play a pivotal role in equalizing access and acceptance of… Continue reading Could Schools Be A Vital Link for Widespread Vaccinations?
Our resources can guide you in sharing your wishes with people important to you.
Tools and resources for adults over the age of 65 and those with pre-existing health risks who at higher risk of severe illness from COVID-19.
A milestone report details the impact of the WHO Surgical Safety Checklist at its 10-year anniversary. Ariadne Labs joins the Population Reference Bureau’s Momentum Knowledge Accelerator, supported by USAID, for maternal, neonatal and child health interventions. Shortly after COVID-19 begins to spread across the U.S., Ariadne Labs Executive Director Asaf Bitton publishes his guide to… Continue reading Our History 2020
July 7, 2021 Ariadne Labs is pleased to announce Namita Seth Mohta, MD, as the new director of the Serious Illness Care Program, following a national search. As director, Dr. Mohta will lead the staff and faculty of the Serious Illness Care Program, establish programmatic vision and strategy, and sustain and expand the program’s portfolio… Continue reading Namita Seth Mohta, MD, to Lead Ariadne Labs Serious Illness Care Program
Free, public tool identifies COVID-19 “vaccine deserts” and helps public health leaders plan for how to equitably deliver the vaccine to the remaining U.S. population lacking access. Vaccine Equity Planner identifies more than 2,000+ primary care sites that are not yet offering vaccines that are located in vaccine deserts. BOSTON, June 9, 2021 — Today,… Continue reading Vaccine Equity Planner Launched by Ariadne Labs and Boston Children’s Hospital